EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Adding Antimicrobial Stewardship Pharmacists to the Infectious Diseases Compensation Discussion: A More Perfect Union?

Keenan Levy Ryan iD, Meghan Jeffres, Krutika Mediwala Hornback iD, Katherine Lusardi, Elizabeth B Hirsch iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad722 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Keenan Levy Ryan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inpatient Pharmacy Department, University of New Mexico Hospital, Albuquerque, New Mexico, USA. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Pharmacists, Communicable Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor—We applaud Swartz and Aberg on their viewpoints regarding the value of infectious disease (ID) physicians (IDP) and the risks of undercompensation [1]. Although the authors advocate for integration of advanced practice individuals to increase efficiency, we propose that ID-trained pharmacists—who routinely perform the real-time patient-level review of antimicrobials—could be a catalyst toward more equitable reimbursement for ID clinicians/divisions. This letter attempts to contextualize these issues and propose a solution. ID is a unique specialty in that antimicrobials are a shared resource and the subsequent antimicrobial resistance is communal. Thus, market forces created a narrow-scope subspecialty of antimicrobial stewardship programs (ASP) to shepherd antimicrobials. Pharmacists often have formal ASP responsibilities, which incorporate many, but not all, of the same evaluations IDPs employ for consults [2]. Recommendations by the IDSA, Society of Healthcare Epidemiology, and The Joint Commission include multidisciplinary telehealth as an alternative to in-person teams. The coronavirus disease 2019 (COVID-19) pandemic and expansion of various health systems to increase access for patients have increased adoption of off-site ID consultant review with recommendations to on-site teams [3].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipPharmacistsCommunicable DiseasesHumansAnti-Bacterial Agents

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Inpatient Pharmacy Department, University of New Mexico Hospital, Albuquerque, New Mexico, USA.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pharmacy, Medical University of South Carolina (MUSC) Health, Charleston, South Carolina, USA.
  • Department of Pharmacy, Baptist Health System, Little Rock, Arkansas, USA.
  • Department of Experimental & Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.

ORCID-Profile: Keenan Levy Ryan, Krutika Mediwala Hornback, Elizabeth B Hirsch

Zitieren

APA

Ryan, K. L., Jeffres, M., Hornback, K. M., Lusardi, K., & Hirsch, E. B. (2024). Adding Antimicrobial Stewardship Pharmacists to the Infectious Diseases Compensation Discussion: A More Perfect Union?. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad722

Vancouver

Ryan KL, Jeffres M, Hornback KM, Lusardi K, Hirsch EB. Adding Antimicrobial Stewardship Pharmacists to the Infectious Diseases Compensation Discussion: A More Perfect Union?. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad722

BibTeX
@article{Ryan2024,
  author = {Ryan, Keenan Levy and Jeffres, Meghan and Hornback, Krutika Mediwala and Lusardi, Katherine and Hirsch, Elizabeth B},
  title = {Adding Antimicrobial Stewardship Pharmacists to the Infectious Diseases Compensation Discussion: A More Perfect Union?},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad722}
}
Kostenlos starten →